NDC 24822-525

Celontin

Methsuximide

Celontin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Farmea. The primary component is Methsuximide.

Product ID24822-525_abac6b2e-bcd8-29c2-e053-2a95a90a2239
NDC24822-525
Product TypeHuman Prescription Drug
Proprietary NameCelontin
Generic NameMethsuximide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1999-01-01
Marketing CategoryNDA /
Application NumberNDA010596
Labeler NameFarmea
Substance NameMETHSUXIMIDE
Active Ingredient Strength300 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Drug Details

NDC Crossover Matching brand name "Celontin" or generic name "Methsuximide"

NDCBrand NameGeneric Name
0071-0525Celontinmethsuximide
24822-525CelontinMETHSUXIMIDE

Trademark Results [Celontin]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CELONTIN
CELONTIN
72011399 0642512 Live/Registered
PARKE, DAVIS & COMPANY
1956-07-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.